Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Chemical structure of (a) AZD2014 (b) AZD8055. | Download Scientific ...
Structure of AZD3582. | Download Scientific Diagram
AZD9574 selectively inhibits and traps PARP1. A, Chemical structure of ...
2 The chemical structure of radiolabelled AZD1152-HQPA. | Download ...
Effect of AZD5305 on PARP2 retention on DNA. (A) The crystal structure ...
Molecular structure of AZD1305. | Download Scientific Diagram
AZD8055 | mTOR Pathway Inhibitor | STEMCELL Technologies
Adenosine triphosphate-competitive mTOR inhibition suppresses T cell ...
AZD8055 blocks radiation-induced mTOR phosphorylation and sensitizes ...
AZD8055 CAS#: 1009298-09-2
AZD8055 is an ATP-competitive mTOR kinase inhibitor. A, chemical ...
AZD8055抑制胆管癌细胞HuCCT1的迁移及EMT进程的机制研究
Reversal of phenotypes of cellular senescence by pan-mTOR inhibition ...
Emerging ADC Targets: B7-H3 and B7-H4
p70核糖体蛋白S6激酶抑制剂的研究进展
Oncology Reports
AZD8055 | mTOR Inhibitor | CAS 1009298-09-2 | Selleck Chemicals
Inhibition of mTOR Kinase by AZD8055 Can Antagonize Chemotherapy ...
AZD8055 - Potent mTOR Kinase Inhibitor | APExBIO
AZD8055 – 美仑生物
AZD8055 FuMaric acid 1201799-05-4 wiki
AZD8055 | CAS 1009298-09-2 | SCBT - Santa Cruz Biotechnology
Schematic representation of AZD8055/OSI-027 induced apoptotic pathway ...
AZD8055 inhibits mTOR, cap-dependent protein translation and elicits a ...
What is the Rapamycin Dose / Dosage for Anti-Aging or Longevity ...
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive ...
AZD8055 D(-)-Tartaric Acid | C29H37N5O10 | CID 77592194 - PubChem
AZD8055 inhibits protein synthesis and up-regulates phosphorylation of ...
The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in ...
AZD8055 inhibited cell viability and enhanced IR-induced cell growth ...
AZD8055 inhibits T cell IFNγ production at day 10 posttransplant ...
AZD8055 inhibits cell proliferation of primary bovine mammary ...
AZD8055 prolongs allograft survival and enhances graft-infiltrating ...
AZD8055 improves muscle mass and reduces abnormal desmin accumulation ...
Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer ...
AZD8055 inhibits mTORC1 and mTORC2 activation simultaneously and ...
美国APExBIO中文官网 - AZD8055|MTOR inhibitor|CAS# 1009298-09-2
AZD8055 Exerts Antitumor Effects on Colon Cancer Cells by Inhibiting ...
AZD8055 treatment suppresses the expression of pro-inflammatory ...
A, the AZD8055/selumetinib combination cooperatively suppressed 4E-BP1 ...
AZD8055 induces whole-body insulin resistance and impairs mTOR ...
Oncology Letters
AZD8055 impairs cell lines proliferation. Cells were treated with ...
AZD8055 enhanced IR-induced G2/M cell cycle arrest and apoptosis. (A ...
Adenosine Triphosphate-Competitive mTOR Inhibitors: A New Class of ...
AZD8055 combined with PD0325901 impairs synergically cell lines ...
The combination of DT2216 and AZD8055 has stronger antitumor responses ...
In vitro transport and in vivo pharmacokinetics of AZD8055. A ...
Effect of AZD8055 on radiosensitivity of NPC xenografts in mice with IR ...
Antitumor Effect of mTOR1/2 Dual Inhibitor AZD8055 in Canine Pulmonary ...
MYC drives AZD8055 resistance in vitro. (A) Western blots for MYC and ...
AZD8055, an mTOR kinase inhibitor, shows in vitro and in vivo ...
AZD8055 attenuates the development of intestinal inflammation. When the ...
AZD8055 inhibits cell growth by blocking p-mTOR S 2481 /p-AKT S 473 ...
AZD8055 - Chemietek
mTOR inhibitor AZD8055 selectively suppresses MCL-1 expression in tumor ...
DT2216+AZD8055 combination synergistically kills BCL-X L /MCL-1 ...
AZD8055 | CAS 1009298-09-2 | AbMole BioScience | AZD8055 Price
Summary of drug interaction for the combination of AZD8055 and azoles ...
AZD-8055-产品信息-Felix
Effect of low-dose AZD8055 on radiosensitivities and toxicities of NPC ...
AZD8055 inhibits glycolysis of human cervical cancer HeLa cells. (A ...
Differences in the antiproliferative capacity of AZD8055 and rapamycin ...
Upregulation of MYC in AZD8055-resistant KEP tumors. (A) Scheme ...
Mean cell diameter on AZD8055 treatment. | Download Table
AZD8055 treatment leads to a decrease in the percentage of CD4+ T cells ...
Diagrammatic representation of signaling proteins and pathways ...
An mTOR inhibitor AZD8055 preferentially inhibited proliferation and ...
mTOR kinase inhibition causes feedback-dependent biphasic regulation of ...
The combination of Upadacitinib and AZD8055 showed synergy with ...
Figure 4 from mTOR kinase inhibitor AZD8055 enhances the ...
AZD8055 | mTOR 阻害剤
Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired ...
MYC is a clinically significant driver of mTOR inhibitor resistance in ...
Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with ...
Inhibition of mTOR signaling reduces PELP1-mediated tumor growth and ...
AZD8055 Supplier | CAS 1009298-09-2 | Focus Biomolecules
Benefits of AZD8055 and AZD2014 over rapamycin to inhibit PI3K/Akt/mTOR ...
AZD8055 | CAS:1009298-09-2 | Manufacturer ChemFaces
Effect of TOR kinase inhibition by AZD8055 on cellular morphology, NPQ ...
How does AstraZeneca's PARP inhibitor differentiate?
医药魔方
AZD8154 | PI3Kγδ Inhibitor | MedChemExpress
AZD-5462 | Selleck Chemicals
ISSX 2022 - Hypha Discovery
ALN (Aluminum Nitride): Formula, Structure, and Applications - Great ...
AZD-1305 | Antiarrhythmic Agent | MedChemExpress
AZD1656 | Carbohydrate Metabolism activator | CAS 919783-22-5 | Selleck
阿斯利康AZD批准8205临床试验申请-试药员招聘与临床试验信息平台
-2.jpg)
